Why is Infinium Pharma falling/rising?

As of 08-Aug, Infinium Pharmachem Ltd is experiencing a decline in its stock price, currently at 256.35, reflecting a decrease of 13.5 points or 5.0%. The stock has underperformed its sector by 3.84% today, and it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has dropped by 6.00%, and it has seen a significant decline of 10.99% over the past month. However, there has been a notable increase in investor participation, with delivery volume rising by 240% against the 5-day average, indicating some interest despite the overall negative performance. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.
In the broader market context, Infinium Pharmachem's performance has been weaker compared to the benchmark Sensex, which has only declined by 0.82% over the past week. Year-to-date, the stock has fallen by 14.52%, while the Sensex has gained 3.04%, highlighting a significant underperformance relative to the market. This trend suggests that while the overall market may be stabilizing or improving, Infinium Pharmachem is struggling to maintain investor confidence, contributing to its declining stock price.